Canton Strategic Holdings (CNTN) Shares Outstanding (Weighted Average) (2020 - 2026)

Canton Strategic Holdings (CNTN) reported Shares Outstanding (Weighted Average) of $207.7 million for Q1 2026, up 7973.41% on a YoY basis from $2.6 million in Q1 2025, and up 548.08% quarter-over-quarter from $32.0 million in Q4 2025.

Canton Strategic Holdings (CNTN) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Canton Strategic Holdings has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $207.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 7973.41% year-over-year to $207.7 million; the trailing twelve-month figure through Mar 2026 stood at $207.7 million (up 7973.41% YoY), and the FY2025 full-year result was $32.0 million, up 6425.27% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $207.7 million, up from $32.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $207.7 million in Q1 2026, with the low at $7500.0 in Q1 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $16.2 million across 5 years, with a median of $1.3 million in 2024.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) slumped 99.6% — and 2025, when it surged 34202.87%.
  • Canton Strategic Holdings' Shares Outstanding (Weighted Average) stood at $452686.0 in 2022, then tumbled by 80.76% to $87079.0 in 2023, then soared by 1388.64% to $1.3 million in 2024, then jumped by 2372.39% to $32.0 million in 2025, then soared by 548.08% to $207.7 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $207.7 million (Q1 2026), $32.0 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 Canton Strategic Holdings 699.97 Mn 658.44 Mn - 207.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 207.71 Mn
Dec 31, 2025 32.05 Mn
Sep 30, 2025 3.91 Mn
Jun 30, 2025 2.73 Mn
Mar 31, 2025 2.57 Mn
Dec 31, 2024 1.30 Mn
Sep 30, 2024 1.55 Mn
Jun 30, 2024 20,000.00
Mar 31, 2024 7,500.00
Dec 31, 2023 87,079.00
Sep 30, 2023 46,169.00
Jun 30, 2023 44,889.00
Mar 31, 2023 187,500.00
Dec 31, 2022 452,686.00
Sep 30, 2022 11.25 Mn
Jun 30, 2022 11.10 Mn
Mar 31, 2022 187,500.00
Dec 31, 2021 6.36 Mn
Sep 30, 2021 6.36 Mn
Jun 30, 2021 6.36 Mn